651P Efficacy and safety outcomes of Phase II study of SCC244 in NSCLC patients harboring MET exon 14 skipping (METex14) mutations (GLORY study): Long-term follow-up analysis

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Biology

Quantum Mechanics

Physics

Medicine

Optics

Show all topics

DOI

10.1016/j.annonc.2024.10.684